Hypertrophic Cardiomyopathy in Review: ESC–HFA 2022 & How to Differentiate HCM From Its Phenocopies

Published: 06 June 2022

  • Views:

    Views Icon 714
  • Likes:

    Heart Icon 0

Overview

Full programme

Overview

In this two-part hypertrophic cardiomyopathy video series, Dr Ahmad Masri discusses important cardiomyopathy data that has been presented at the ESC–HFA annual congress 2022 and how to differentiate HCM from other conditions that frequently mask, or mimic the diagnosis of HCM.

 

Supported through an educational grant from Bristol Myers Squibb

Learning Objectives

  • Recall the efficacy and safety of existing HCM treatments and summarise results from ongoing trials with experimental treatments
  • Differentiate the signs and symptoms of HCM from other conditions that frequently mask, or mimic the disease and in the presence of comorbidities

Target Audience

  • Cardiologists
  • Heart failure specialists
  • Allied healthcare professionals

Series overview

Part 2

How to Differentiate HCM From Its Phenocopies

Faculty Biographies

Ahmad Masri

Ahmad Masri

Dr Ahmad Masri M.D., M.S. trained in Internal Medicine at the Cleveland Clinic.

He specialises in caring for patients with conditions that result in abnormally thickened hearts, such as hypertrophic cardiomyopathy, amyloidosis and Fabry’s disease.

View full profile